OBJECTIVE: To assess the long-term performance of the bifurcated Zenith stent graft. METHODS: A total of 325 patients (300 men and 25 women) underwent elective endovascular abdominal aortic aneurysm repair with bifurcated Zenith stent grafts between October 1998 and December 2005. Follow-up included routine contrast-enhanced computed tomography and multiview abdominal radiographs at 1, 6, and 12 months and yearly thereafter. Data on late-occurring (>30 days after stent-graft implantation) complications and interventions were collected prospectively. RESULTS: Of the original 325 patients, 92 have since died, resulting in a mean follow-up of 2.3 years (range, 1 month to 7.0 years). Nine (2.8%) of 325 patients required reintervention to treat or prevent endoleak (type I or III) or graft occlusion at an average of 1.4 years after stent-graft placement (range, 40 days to 4.0 years). Three (0.9%) of these patients died from causes related to malfunction of the stent graft: one each from aneurysm rupture, stent-graft infection, and infection of a femoral-femoral bypass graft placed after limb occlusion. Nineteen additional patients (5.8%) required treatment for type II endoleak, for a total reintervention rate of 8.6%. CONCLUSIONS: Late failures of Zenith stent-graft attachment, structure, or function are rare. In the absence of known endoleak, routine follow-up imaging plays a limited role in the identification and prevention of impending failure.
OBJECTIVE: To assess the long-term performance of the bifurcated Zenith stent graft. METHODS: A total of 325 patients (300 men and 25 women) underwent elective endovascular abdominal aortic aneurysm repair with bifurcated Zenith stent grafts between October 1998 and December 2005. Follow-up included routine contrast-enhanced computed tomography and multiview abdominal radiographs at 1, 6, and 12 months and yearly thereafter. Data on late-occurring (>30 days after stent-graft implantation) complications and interventions were collected prospectively. RESULTS: Of the original 325 patients, 92 have since died, resulting in a mean follow-up of 2.3 years (range, 1 month to 7.0 years). Nine (2.8%) of 325 patients required reintervention to treat or prevent endoleak (type I or III) or graft occlusion at an average of 1.4 years after stent-graft placement (range, 40 days to 4.0 years). Three (0.9%) of these patients died from causes related to malfunction of the stent graft: one each from aneurysm rupture, stent-graft infection, and infection of a femoral-femoral bypass graft placed after limb occlusion. Nineteen additional patients (5.8%) required treatment for type II endoleak, for a total reintervention rate of 8.6%. CONCLUSIONS: Late failures of Zenith stent-graft attachment, structure, or function are rare. In the absence of known endoleak, routine follow-up imaging plays a limited role in the identification and prevention of impending failure.
Authors: A Canì; E Cotta; C Recaldini; D Lumia; F Fontana; G Carrafiello; V Colli; C Fugazzola Journal: Radiol Med Date: 2011-06-04 Impact factor: 3.469
Authors: Joel L Ramirez; Melinda S Schaller; Bian Wu; Linda M Reilly; Timothy A M Chuter; Jade S Hiramoto Journal: J Vasc Surg Date: 2019-05-27 Impact factor: 4.268
Authors: Jade S Hiramoto; Catherine K Chang; Linda M Reilly; Darren B Schneider; Joseph H Rapp; Timothy A M Chuter Journal: J Vasc Surg Date: 2009-02-23 Impact factor: 4.268
Authors: Catherine K Chang; Timothy A M Chuter; Claus U Niemann; Michael G Shlipak; Mitchell J Cohen; Linda M Reilly; Jade S Hiramoto Journal: J Vasc Surg Date: 2009-05 Impact factor: 4.268